ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diclofenac Transdermal Patches Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-37A11529
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Diclofenac Transdermal Patches Market Research Report 2022
BUY CHAPTERS

Global Diclofenac Transdermal Patches Market Research Report 2024

Code: QYRE-Auto-37A11529
Report
May 2024
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Saintroy Lifescience
Hisamitsu Pharmaceutical Co Inc
Sparsha Pharma
SK-Pharma
Maiden Pharmaceuticals Ltd.
Zuventus Healthcare Ltd
Azista Industries
IBSA

Diclofenac Transdermal Patches Market Size

The global Diclofenac Transdermal Patches market was valued at US$ 2581 million in 2023 and is anticipated to reach US$ 4419 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.

Diclofenac Transdermal Patches Market

Diclofenac Transdermal Patches Market

Transdermal diclofenac is used to treat short-term pain due to minor strains, sprains, and bruises in adults and children 6 years of age and older. Diclofenac is in a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by stopping the body's production of a substance that causes pain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diclofenac Transdermal Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diclofenac Transdermal Patches.

Report Scope

The Diclofenac Transdermal Patches market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diclofenac Transdermal Patches market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diclofenac Transdermal Patches manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Diclofenac Transdermal Patches Market Report

Report Metric Details
Report Name Diclofenac Transdermal Patches Market
Accounted market size in 2023 US$ 2581 million
Forecasted market size in 2030 US$ 4419 million
CAGR 3.2%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • 12 Hours
  • 24 Hours
Segment by Application
  • Online Sales
  • Drugstore Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company IBSA, Sparsha Pharma, SK-Pharma, Saintroy Lifescience, Maiden Pharmaceuticals Ltd., Zuventus Healthcare Ltd, Hisamitsu Pharmaceutical Co., Inc., Azista Industries
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Diclofenac Transdermal Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Diclofenac Transdermal Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Diclofenac Transdermal Patches Market growing?

Ans: The Diclofenac Transdermal Patches Market witnessing a CAGR of 3.2% during the forecast period 2024-2030.

What is the Diclofenac Transdermal Patches Market size in 2030?

Ans: The Diclofenac Transdermal Patches Market size in 2030 will be US$ 4419 million.

Who are the main players in the Diclofenac Transdermal Patches Market report?

Ans: The main players in the Diclofenac Transdermal Patches Market are IBSA, Sparsha Pharma, SK-Pharma, Saintroy Lifescience, Maiden Pharmaceuticals Ltd., Zuventus Healthcare Ltd, Hisamitsu Pharmaceutical Co., Inc., Azista Industries

What are the Application segmentation covered in the Diclofenac Transdermal Patches Market report?

Ans: The Applications covered in the Diclofenac Transdermal Patches Market report are Online Sales, Drugstore Sales

What are the Type segmentation covered in the Diclofenac Transdermal Patches Market report?

Ans: The Types covered in the Diclofenac Transdermal Patches Market report are 12 Hours, 24 Hours

1 Diclofenac Transdermal Patches Market Overview
1.1 Product Overview and Scope of Diclofenac Transdermal Patches
1.2 Diclofenac Transdermal Patches Segment by Type
1.2.1 Global Diclofenac Transdermal Patches Market Value Comparison by Type (2024-2030)
1.2.2 12 Hours
1.2.3 24 Hours
1.3 Diclofenac Transdermal Patches Segment by Application
1.3.1 Global Diclofenac Transdermal Patches Market Value by Application: (2024-2030)
1.3.2 Online Sales
1.3.3 Drugstore Sales
1.4 Global Diclofenac Transdermal Patches Market Size Estimates and Forecasts
1.4.1 Global Diclofenac Transdermal Patches Revenue 2019-2030
1.4.2 Global Diclofenac Transdermal Patches Sales 2019-2030
1.4.3 Global Diclofenac Transdermal Patches Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diclofenac Transdermal Patches Market Competition by Manufacturers
2.1 Global Diclofenac Transdermal Patches Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diclofenac Transdermal Patches Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diclofenac Transdermal Patches Average Price by Manufacturers (2019-2024)
2.4 Global Diclofenac Transdermal Patches Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diclofenac Transdermal Patches, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diclofenac Transdermal Patches, Product Type & Application
2.7 Diclofenac Transdermal Patches Market Competitive Situation and Trends
2.7.1 Diclofenac Transdermal Patches Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diclofenac Transdermal Patches Players Market Share by Revenue
2.7.3 Global Diclofenac Transdermal Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diclofenac Transdermal Patches Retrospective Market Scenario by Region
3.1 Global Diclofenac Transdermal Patches Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diclofenac Transdermal Patches Global Diclofenac Transdermal Patches Sales by Region: 2019-2030
3.2.1 Global Diclofenac Transdermal Patches Sales by Region: 2019-2024
3.2.2 Global Diclofenac Transdermal Patches Sales by Region: 2025-2030
3.3 Global Diclofenac Transdermal Patches Global Diclofenac Transdermal Patches Revenue by Region: 2019-2030
3.3.1 Global Diclofenac Transdermal Patches Revenue by Region: 2019-2024
3.3.2 Global Diclofenac Transdermal Patches Revenue by Region: 2025-2030
3.4 North America Diclofenac Transdermal Patches Market Facts & Figures by Country
3.4.1 North America Diclofenac Transdermal Patches Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diclofenac Transdermal Patches Sales by Country (2019-2030)
3.4.3 North America Diclofenac Transdermal Patches Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Diclofenac Transdermal Patches Market Facts & Figures by Country
3.5.1 Europe Diclofenac Transdermal Patches Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diclofenac Transdermal Patches Sales by Country (2019-2030)
3.5.3 Europe Diclofenac Transdermal Patches Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diclofenac Transdermal Patches Market Facts & Figures by Country
3.6.1 Asia Pacific Diclofenac Transdermal Patches Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diclofenac Transdermal Patches Sales by Country (2019-2030)
3.6.3 Asia Pacific Diclofenac Transdermal Patches Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Diclofenac Transdermal Patches Market Facts & Figures by Country
3.7.1 Latin America Diclofenac Transdermal Patches Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diclofenac Transdermal Patches Sales by Country (2019-2030)
3.7.3 Latin America Diclofenac Transdermal Patches Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diclofenac Transdermal Patches Market Facts & Figures by Country
3.8.1 Middle East and Africa Diclofenac Transdermal Patches Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diclofenac Transdermal Patches Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diclofenac Transdermal Patches Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diclofenac Transdermal Patches Sales by Type (2019-2030)
4.1.1 Global Diclofenac Transdermal Patches Sales by Type (2019-2024)
4.1.2 Global Diclofenac Transdermal Patches Sales by Type (2025-2030)
4.1.3 Global Diclofenac Transdermal Patches Sales Market Share by Type (2019-2030)
4.2 Global Diclofenac Transdermal Patches Revenue by Type (2019-2030)
4.2.1 Global Diclofenac Transdermal Patches Revenue by Type (2019-2024)
4.2.2 Global Diclofenac Transdermal Patches Revenue by Type (2025-2030)
4.2.3 Global Diclofenac Transdermal Patches Revenue Market Share by Type (2019-2030)
4.3 Global Diclofenac Transdermal Patches Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diclofenac Transdermal Patches Sales by Application (2019-2030)
5.1.1 Global Diclofenac Transdermal Patches Sales by Application (2019-2024)
5.1.2 Global Diclofenac Transdermal Patches Sales by Application (2025-2030)
5.1.3 Global Diclofenac Transdermal Patches Sales Market Share by Application (2019-2030)
5.2 Global Diclofenac Transdermal Patches Revenue by Application (2019-2030)
5.2.1 Global Diclofenac Transdermal Patches Revenue by Application (2019-2024)
5.2.2 Global Diclofenac Transdermal Patches Revenue by Application (2025-2030)
5.2.3 Global Diclofenac Transdermal Patches Revenue Market Share by Application (2019-2030)
5.3 Global Diclofenac Transdermal Patches Price by Application (2019-2030)
6 Key Companies Profiled
6.1 IBSA
6.1.1 IBSA Corporation Information
6.1.2 IBSA Description and Business Overview
6.1.3 IBSA Diclofenac Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.1.4 IBSA Diclofenac Transdermal Patches Product Portfolio
6.1.5 IBSA Recent Developments/Updates
6.2 Sparsha Pharma
6.2.1 Sparsha Pharma Corporation Information
6.2.2 Sparsha Pharma Description and Business Overview
6.2.3 Sparsha Pharma Diclofenac Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sparsha Pharma Diclofenac Transdermal Patches Product Portfolio
6.2.5 Sparsha Pharma Recent Developments/Updates
6.3 SK-Pharma
6.3.1 SK-Pharma Corporation Information
6.3.2 SK-Pharma Description and Business Overview
6.3.3 SK-Pharma Diclofenac Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.3.4 SK-Pharma Diclofenac Transdermal Patches Product Portfolio
6.3.5 SK-Pharma Recent Developments/Updates
6.4 Saintroy Lifescience
6.4.1 Saintroy Lifescience Corporation Information
6.4.2 Saintroy Lifescience Description and Business Overview
6.4.3 Saintroy Lifescience Diclofenac Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Saintroy Lifescience Diclofenac Transdermal Patches Product Portfolio
6.4.5 Saintroy Lifescience Recent Developments/Updates
6.5 Maiden Pharmaceuticals Ltd.
6.5.1 Maiden Pharmaceuticals Ltd. Corporation Information
6.5.2 Maiden Pharmaceuticals Ltd. Description and Business Overview
6.5.3 Maiden Pharmaceuticals Ltd. Diclofenac Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Maiden Pharmaceuticals Ltd. Diclofenac Transdermal Patches Product Portfolio
6.5.5 Maiden Pharmaceuticals Ltd. Recent Developments/Updates
6.6 Zuventus Healthcare Ltd
6.6.1 Zuventus Healthcare Ltd Corporation Information
6.6.2 Zuventus Healthcare Ltd Description and Business Overview
6.6.3 Zuventus Healthcare Ltd Diclofenac Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Zuventus Healthcare Ltd Diclofenac Transdermal Patches Product Portfolio
6.6.5 Zuventus Healthcare Ltd Recent Developments/Updates
6.7 Hisamitsu Pharmaceutical Co., Inc.
6.6.1 Hisamitsu Pharmaceutical Co., Inc. Corporation Information
6.6.2 Hisamitsu Pharmaceutical Co., Inc. Description and Business Overview
6.6.3 Hisamitsu Pharmaceutical Co., Inc. Diclofenac Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hisamitsu Pharmaceutical Co., Inc. Diclofenac Transdermal Patches Product Portfolio
6.7.5 Hisamitsu Pharmaceutical Co., Inc. Recent Developments/Updates
6.8 Azista Industries
6.8.1 Azista Industries Corporation Information
6.8.2 Azista Industries Description and Business Overview
6.8.3 Azista Industries Diclofenac Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Azista Industries Diclofenac Transdermal Patches Product Portfolio
6.8.5 Azista Industries Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diclofenac Transdermal Patches Industry Chain Analysis
7.2 Diclofenac Transdermal Patches Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diclofenac Transdermal Patches Production Mode & Process
7.4 Diclofenac Transdermal Patches Sales and Marketing
7.4.1 Diclofenac Transdermal Patches Sales Channels
7.4.2 Diclofenac Transdermal Patches Distributors
7.5 Diclofenac Transdermal Patches Customers
8 Diclofenac Transdermal Patches Market Dynamics
8.1 Diclofenac Transdermal Patches Industry Trends
8.2 Diclofenac Transdermal Patches Market Drivers
8.3 Diclofenac Transdermal Patches Market Challenges
8.4 Diclofenac Transdermal Patches Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Saintroy Lifescience
Hisamitsu Pharmaceutical Co Inc
Sparsha Pharma
SK-Pharma
Maiden Pharmaceuticals Ltd.
Zuventus Healthcare Ltd
Azista Industries
IBSA
List of Tables
    Table 1. Global Diclofenac Transdermal Patches Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Diclofenac Transdermal Patches Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Diclofenac Transdermal Patches Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Diclofenac Transdermal Patches Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Diclofenac Transdermal Patches Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Diclofenac Transdermal Patches Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Diclofenac Transdermal Patches Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Diclofenac Transdermal Patches Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Diclofenac Transdermal Patches, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Diclofenac Transdermal Patches, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Diclofenac Transdermal Patches, Product Type & Application
    Table 12. Global Key Manufacturers of Diclofenac Transdermal Patches, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Diclofenac Transdermal Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diclofenac Transdermal Patches as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Diclofenac Transdermal Patches Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Diclofenac Transdermal Patches Sales by Region (2019-2024) & (K Units)
    Table 18. Global Diclofenac Transdermal Patches Sales Market Share by Region (2019-2024)
    Table 19. Global Diclofenac Transdermal Patches Sales by Region (2025-2030) & (K Units)
    Table 20. Global Diclofenac Transdermal Patches Sales Market Share by Region (2025-2030)
    Table 21. Global Diclofenac Transdermal Patches Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Diclofenac Transdermal Patches Revenue Market Share by Region (2019-2024)
    Table 23. Global Diclofenac Transdermal Patches Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Diclofenac Transdermal Patches Revenue Market Share by Region (2025-2030)
    Table 25. North America Diclofenac Transdermal Patches Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Diclofenac Transdermal Patches Sales by Country (2019-2024) & (K Units)
    Table 27. North America Diclofenac Transdermal Patches Sales by Country (2025-2030) & (K Units)
    Table 28. North America Diclofenac Transdermal Patches Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Diclofenac Transdermal Patches Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Diclofenac Transdermal Patches Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Diclofenac Transdermal Patches Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Diclofenac Transdermal Patches Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Diclofenac Transdermal Patches Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Diclofenac Transdermal Patches Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Diclofenac Transdermal Patches Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Diclofenac Transdermal Patches Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Diclofenac Transdermal Patches Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Diclofenac Transdermal Patches Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Diclofenac Transdermal Patches Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Diclofenac Transdermal Patches Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Diclofenac Transdermal Patches Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Diclofenac Transdermal Patches Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Diclofenac Transdermal Patches Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Diclofenac Transdermal Patches Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Diclofenac Transdermal Patches Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Diclofenac Transdermal Patches Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Diclofenac Transdermal Patches Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Diclofenac Transdermal Patches Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Diclofenac Transdermal Patches Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Diclofenac Transdermal Patches Sales (K Units) by Type (2019-2024)
    Table 51. Global Diclofenac Transdermal Patches Sales (K Units) by Type (2025-2030)
    Table 52. Global Diclofenac Transdermal Patches Sales Market Share by Type (2019-2024)
    Table 53. Global Diclofenac Transdermal Patches Sales Market Share by Type (2025-2030)
    Table 54. Global Diclofenac Transdermal Patches Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Diclofenac Transdermal Patches Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Diclofenac Transdermal Patches Revenue Market Share by Type (2019-2024)
    Table 57. Global Diclofenac Transdermal Patches Revenue Market Share by Type (2025-2030)
    Table 58. Global Diclofenac Transdermal Patches Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Diclofenac Transdermal Patches Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Diclofenac Transdermal Patches Sales (K Units) by Application (2019-2024)
    Table 61. Global Diclofenac Transdermal Patches Sales (K Units) by Application (2025-2030)
    Table 62. Global Diclofenac Transdermal Patches Sales Market Share by Application (2019-2024)
    Table 63. Global Diclofenac Transdermal Patches Sales Market Share by Application (2025-2030)
    Table 64. Global Diclofenac Transdermal Patches Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Diclofenac Transdermal Patches Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Diclofenac Transdermal Patches Revenue Market Share by Application (2019-2024)
    Table 67. Global Diclofenac Transdermal Patches Revenue Market Share by Application (2025-2030)
    Table 68. Global Diclofenac Transdermal Patches Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Diclofenac Transdermal Patches Price (US$/Unit) by Application (2025-2030)
    Table 70. IBSA Corporation Information
    Table 71. IBSA Description and Business Overview
    Table 72. IBSA Diclofenac Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. IBSA Diclofenac Transdermal Patches Product
    Table 74. IBSA Recent Developments/Updates
    Table 75. Sparsha Pharma Corporation Information
    Table 76. Sparsha Pharma Description and Business Overview
    Table 77. Sparsha Pharma Diclofenac Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Sparsha Pharma Diclofenac Transdermal Patches Product
    Table 79. Sparsha Pharma Recent Developments/Updates
    Table 80. SK-Pharma Corporation Information
    Table 81. SK-Pharma Description and Business Overview
    Table 82. SK-Pharma Diclofenac Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. SK-Pharma Diclofenac Transdermal Patches Product
    Table 84. SK-Pharma Recent Developments/Updates
    Table 85. Saintroy Lifescience Corporation Information
    Table 86. Saintroy Lifescience Description and Business Overview
    Table 87. Saintroy Lifescience Diclofenac Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Saintroy Lifescience Diclofenac Transdermal Patches Product
    Table 89. Saintroy Lifescience Recent Developments/Updates
    Table 90. Maiden Pharmaceuticals Ltd. Corporation Information
    Table 91. Maiden Pharmaceuticals Ltd. Description and Business Overview
    Table 92. Maiden Pharmaceuticals Ltd. Diclofenac Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Maiden Pharmaceuticals Ltd. Diclofenac Transdermal Patches Product
    Table 94. Maiden Pharmaceuticals Ltd. Recent Developments/Updates
    Table 95. Zuventus Healthcare Ltd Corporation Information
    Table 96. Zuventus Healthcare Ltd Description and Business Overview
    Table 97. Zuventus Healthcare Ltd Diclofenac Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Zuventus Healthcare Ltd Diclofenac Transdermal Patches Product
    Table 99. Zuventus Healthcare Ltd Recent Developments/Updates
    Table 100. Hisamitsu Pharmaceutical Co., Inc. Corporation Information
    Table 101. Hisamitsu Pharmaceutical Co., Inc. Description and Business Overview
    Table 102. Hisamitsu Pharmaceutical Co., Inc. Diclofenac Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Hisamitsu Pharmaceutical Co., Inc. Diclofenac Transdermal Patches Product
    Table 104. Hisamitsu Pharmaceutical Co., Inc. Recent Developments/Updates
    Table 105. Azista Industries Corporation Information
    Table 106. Azista Industries Description and Business Overview
    Table 107. Azista Industries Diclofenac Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Azista Industries Diclofenac Transdermal Patches Product
    Table 109. Azista Industries Recent Developments/Updates
    Table 110. Key Raw Materials Lists
    Table 111. Raw Materials Key Suppliers Lists
    Table 112. Diclofenac Transdermal Patches Distributors List
    Table 113. Diclofenac Transdermal Patches Customers List
    Table 114. Diclofenac Transdermal Patches Market Trends
    Table 115. Diclofenac Transdermal Patches Market Drivers
    Table 116. Diclofenac Transdermal Patches Market Challenges
    Table 117. Diclofenac Transdermal Patches Market Restraints
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Diclofenac Transdermal Patches
    Figure 2. Global Diclofenac Transdermal Patches Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Diclofenac Transdermal Patches Market Share by Type in 2023 & 2030
    Figure 4. 12 Hours Product Picture
    Figure 5. 24 Hours Product Picture
    Figure 6. Global Diclofenac Transdermal Patches Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Diclofenac Transdermal Patches Market Share by Application in 2023 & 2030
    Figure 8. Online Sales
    Figure 9. Drugstore Sales
    Figure 10. Global Diclofenac Transdermal Patches Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Diclofenac Transdermal Patches Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Diclofenac Transdermal Patches Sales (2019-2030) & (K Units)
    Figure 13. Global Diclofenac Transdermal Patches Average Price (US$/Unit) & (2019-2030)
    Figure 14. Diclofenac Transdermal Patches Report Years Considered
    Figure 15. Diclofenac Transdermal Patches Sales Share by Manufacturers in 2023
    Figure 16. Global Diclofenac Transdermal Patches Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Diclofenac Transdermal Patches Players: Market Share by Revenue in 2023
    Figure 18. Diclofenac Transdermal Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Diclofenac Transdermal Patches Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Diclofenac Transdermal Patches Sales Market Share by Country (2019-2030)
    Figure 21. North America Diclofenac Transdermal Patches Revenue Market Share by Country (2019-2030)
    Figure 22. United States Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Diclofenac Transdermal Patches Sales Market Share by Country (2019-2030)
    Figure 25. Europe Diclofenac Transdermal Patches Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Diclofenac Transdermal Patches Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Diclofenac Transdermal Patches Revenue Market Share by Region (2019-2030)
    Figure 33. China Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. China Taiwan Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Latin America Diclofenac Transdermal Patches Sales Market Share by Country (2019-2030)
    Figure 43. Latin America Diclofenac Transdermal Patches Revenue Market Share by Country (2019-2030)
    Figure 44. Mexico Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Brazil Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Argentina Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Diclofenac Transdermal Patches Sales Market Share by Country (2019-2030)
    Figure 48. Middle East & Africa Diclofenac Transdermal Patches Revenue Market Share by Country (2019-2030)
    Figure 49. Turkey Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Saudi Arabia Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. UAE Diclofenac Transdermal Patches Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Global Sales Market Share of Diclofenac Transdermal Patches by Type (2019-2030)
    Figure 53. Global Revenue Market Share of Diclofenac Transdermal Patches by Type (2019-2030)
    Figure 54. Global Diclofenac Transdermal Patches Price (US$/Unit) by Type (2019-2030)
    Figure 55. Global Sales Market Share of Diclofenac Transdermal Patches by Application (2019-2030)
    Figure 56. Global Revenue Market Share of Diclofenac Transdermal Patches by Application (2019-2030)
    Figure 57. Global Diclofenac Transdermal Patches Price (US$/Unit) by Application (2019-2030)
    Figure 58. Diclofenac Transdermal Patches Value Chain
    Figure 59. Diclofenac Transdermal Patches Production Process
    Figure 60. Channels of Distribution (Direct Vs Distribution)
    Figure 61. Distributors Profiles
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Piperacillin and Tazobactam API Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-5N8884
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Gonadotropin-releasing Hormone Agonist Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-22J896
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Topical Scar Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6S8304
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Artesunate Used for Malaria Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-17P8208
Sun May 19 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions